The RheoScan system can measure rheological properties of blood (i.e., RBC deformability, aggregation, critical stress etc) at research and clinical environments. With adopting leading-edge technologies such as laser-optics and microfluidics, the RheoScan system can provide quick and easy measurements with high precision and repeatability. ​In recent clinical researches, RheoScan has been found to diagnose Metabolic syndrome and diabetic kidney diseases at an earlier stages.

Anysis, an innovative platelet function test, can evaluate platelet function as well as anti-platelets drug response such as aspirin test and P2Y12 test. Anysis provides results with less than 3 minutes with just 200uL of whole blood. The Anysis’s unique technology adopts in-vivo hemodynamic conditions for simulating platelet activation, adhesion, and aggregation in a vascular lumen, Thus, Anysis can provide simple, rapid detection of congenital, inherited and acquired platelet dysfunction even at clinical env.